Capital Asset Advisory Services’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Capital Asset Advisory Services’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,603	Closed	-$260K	–	570
2020 Q2	$260K	Buy	+1,603	New	+$252K	0.06%	280
2019 Q2	–	Sell	-2,845	Closed	-$429K	–	110
2019 Q1	$429K	Sell	2,845 -1,568	-36%	-$226K	0.56%	32
2018 Q4	$548K	Sell	4,413 -218	-5%	-$29.8K	0.52%	43
2018 Q3	$734K	Sell	4,631 -4	-0.1%	-$605	0.62%	37
2018 Q2	$649K	Sell	4,635 -247	-5%	-$33.9K	0.59%	40
2018 Q1	$649K	Buy	4,882 +124	+3%	+$16.9K	0.6%	41
2017 Q4	$593K	Sell	4,758 -765	-14%	-$94.5K	0.54%	50
2017 Q3	$684K	Buy	5,523 +86	+2%	+$10.2K	0.62%	43
2017 Q2	$624K	Buy	+5,437	New	+$585K	0.4%	60

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Capital Asset Advisory Services's FBT Position: Q3 2020 in Review

Capital Asset Advisory Services sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2020, closing a stake of 1,603 shares — an estimated $260K sold.

Capital Asset Advisory Services first reported a position in FBT in Q2 2017 and held it in 9 quarters. The position peaked at $734K in Q3 2018. 213 funds tracked by Wall St. Rank hold FBT as of Q3 2020.

Capital Asset Advisory Services reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2020 after selling out during the quarter.
Capital Asset Advisory Services sold 1,603 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2020, an estimated $260K.
Capital Asset Advisory Services first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2017 and held it in 9 quarters.
Capital Asset Advisory Services's First Trust NYSE Arca Biotechnology Index Fund position peaked at $734K in Q3 2018.
213 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2020.

Based on Capital Asset Advisory Services's 13F filing for Q3 2020, filed 18 Nov 2020.